These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23715170)

  • 21. Evaluation of platelet reactivity during combined antiplatelet therapy in patients with stable coronary artery disease in relation to diabetes type 2 and the GPIIB/IIIA receptor gene polymorphism.
    Jastrzebska M; Lisman D; Szelepajlo A; Oledzki S; Chelstowski K; Clark JS; Siennicka A
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers.
    Andersson T; Morrison D; Nagy P; Pisupati J; Schettler J; Warner TD
    Am J Cardiovasc Drugs; 2012 Aug; 12(4):217-24. PubMed ID: 22631032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.
    González-Correa JA; Muñoz-Marín J; López-Villodres JA; Navas MD; Guerrero A; Torres JA; De La Cruz JP
    Pharmacol Res; 2007 Aug; 56(2):168-74. PubMed ID: 17644353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salicylic acid retention impairs aspirin reactivity in type 2 diabetes.
    Zhang H; Xie H; Zheng X; Chai Y; Tang Z; Chen H; Li F; Christoph H; Chen J; Sun W; Ye H; Wang S; Hao H; Chen X
    Eur J Pharmacol; 2017 Jan; 794():234-245. PubMed ID: 27894813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes.
    Harrison P; Bethel MA; Kennedy I; Dinsdale R; Coleman R; Holman RR
    Platelets; 2019; 30(4):521-529. PubMed ID: 29985735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One milligramme of acetylsalicylic acid daily inhibits platelet thromboxane A2 production.
    Toivanen J; Ylikorkala O; Viinikka L
    Thromb Res; 1984 Sep; 35(6):681-7. PubMed ID: 6506023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
    Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
    Patrick J; Dillaha L; Armas D; Sessa WC
    Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction.
    Valles J; Santos MT; Fuset MP; Moscardo A; Ruano M; Perez F; Piñon M; Breña S; Aznar J
    Am J Cardiol; 2007 Jan; 99(1):19-25. PubMed ID: 17196455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
    Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers.
    Benedek IH; Joshi AS; Pieniaszek HJ; King SY; Kornhauser DM
    J Clin Pharmacol; 1995 Dec; 35(12):1181-6. PubMed ID: 8750369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients.
    Luzak B; Boncler M; Rywaniak J; Wilk R; Stanczyk L; Czyz M; Rysz J; Watala C
    Eur J Pharmacol; 2011 May; 658(2-3):91-7. PubMed ID: 21371451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.
    Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
    Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can we use adenosine diphosphate (ADP) to study "aspirin resistance"? The Janus faces of ADP-triggered platelet aggregation.
    Dobaczewski M; Golański J; Kowalski T; Nocuń M; Rózalski M; Kostka B; Ulicna O; Mussur M; Markuszewski L; Watała C
    Pharmacol Rep; 2008; 60(3):361-8. PubMed ID: 18622061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between High On-Aspirin Platelet Reactivity and Reduced Superoxide Dismutase Activity in Patients Affected by Type 2 Diabetes Mellitus or Primary Hypercholesterolemia.
    Barale C; Cavalot F; Frascaroli C; Bonomo K; Morotti A; Guerrasio A; Russo I
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to acetylsalicylic acid in patients after ischemic stroke.
    Zytkiewicz M; Giełwanowska L; Wojtasińska E; Psuja P; Zawilska K
    Pol Arch Med Wewn; 2008 Dec; 118(12):727-33. PubMed ID: 19202951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin.
    Scavone M; Rizzo J; Femia EA; Podda GM; Bossi E; Caberlon S; Paroni R; Cattaneo M
    Thromb Haemost; 2020 Oct; 120(10):1442-1453. PubMed ID: 32717754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.